Design Therapeutics, Inc. (DSGN:NASDAQ) closed at $9.32 on November 19, 2026, down 1.58% on the day. The stock trades 46.0% below its 52-week high of $17.25 and 19.3% above its 52-week low of $7.81. Over the past year, it gained 18.4%. Design Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 19, 2025, DSGN closed higher on 128 days (51%). Its best day was April 29, 2026 (+23.26%) and its worst was May 18, 2026 (-25.54%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Find more stocks like DSGN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.